Fourth quarter 2020 and recent highlights: * demonstrated the Nanox.ARC @ (RSNA) * Added senior leadership team * Expanded anBoD * Expanded collaboration with USARAD
* Signed agreement with Ambra Health * Established a wholly-owned Korean subsidiary * Submitted a comprehensive response to the FDA. The Company expectsregulatory clearance of the single source Nanox.ARC this year * Completed offering of 3.1 million shares by certain non-director, non-officer selling pre-IPO shareholders. The Company did not receive any proceeds from the offering
Bullish
A
Nanox CONFIRMS that they have submitted the requested info
n
To the bears or shorts on this board! Don’t ever say that they didn’t submit paper work for the FDA approval! They just emphasized that they did submit the paperwork and the approval should come quite soon!!!!!!!! Hope you listened to the earning call! Quarter of a billion cash on hand as well!!!! Lots of liquidity!!! And it’s not a drug that is being processed for FDA approval it’s an X-ray machine which has just paperwork!!!! And they will get it for sure within a month!!! It could be next week! Once that happens the stock will triple!!!!! And will not dip under 100$ ever again!
Bullish
A
Finally, I muted Richard. It's a great feeling. It's like finally getting rid of a blister that's been bothering you for a long time.
n
Quite soon that’s what the CEO said today in the conference! Quite soon for the single unit!!! So the FDA approval should be any day now and you won’t ever see anything under 100$
Bullish
M
Many of you can join today’s conference call at 8:30 ET
If Cathie Woods think this stock worth investing, it must be good.
Z
Very encouraging call this morning in my opinion. My biggest takeaway, mute Richard. I'd rather trust the information directly from the company than an outsider that really knows nothing and has been spreading misinformation on this forum.
M
As Im listening CEO is facing some tough questions.
J
Rebound
Bullish
G
I thought the call today was very good. I'm surprised there wasn't a more positive reaction.
There should be an FDA decision in March. Lots of new customer interest after the Dec demo.
Pls read between the lines of what he said about Nanox's potential OEM business and their technology.
Y
What's the reason of fall? I cant understand it
Y
Richard, I think you should be more careful. You could get sued for libel for all the slander you are spreading about NNOX while hiding under a fake handle. I dare guess you wouldn't be so blunt if you had to use your true identity. You should start thinking about your next lie for when FDA approval is given because once recieved it will become much harder for you to argue that they never submitted anything to the FDA. Good luck.
A
If you visit nanox careers, you'll see that they add openings relevant to multi-source application. 1) Verification & Validation, Quality Assurance and regulatory specialist. these new since November. Investors webinar after RSNA mention add regulatory “army” as prep to multi-source application.
* demonstrated the Nanox.ARC @ (RSNA)
* Added senior leadership team
* Expanded anBoD
* Expanded collaboration with USARAD
* Signed agreement with Ambra Health
* Established a wholly-owned Korean subsidiary
* Submitted a comprehensive response to the FDA. The Company expectsregulatory clearance of the single source Nanox.ARC this year
* Completed offering of 3.1 million shares by certain non-director, non-officer selling pre-IPO shareholders. The Company did not receive any proceeds from the offering
https://www.globenewswire.com/Tracker?data=5U6KdaBuGuZ66B1pfAgiVZWy2HYqOzVDYvyGN1MOt78jbfPpqPId3HLn2J5V5lc5J9cuF9zo_Iw2ZwGj-91Gyxw_B0uGncUCXTcabIrLf5x62M-DkY9qydpECprjW9RgL6YYU9nNRJTK06Q1xjoaDg==
Continues to build out commercial and manufacturing infrastructure ahead of initial product shipments expected to commence in Q4 2021 and into Q1 2022
Ended Q4 with cash and cash equivalents of $213 million and no debt
If Cathie Woods think this stock worth investing, it must be good.
There should be an FDA decision in March. Lots of new customer interest after the Dec demo.
Pls read between the lines of what he said about Nanox's potential OEM business and their technology.
You should start thinking about your next lie for when FDA approval is given because once recieved it will become much harder for you to argue that they never submitted anything to the FDA. Good luck.